Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 58.8B | 32.2B | 28.2B | 29.3B |
Cost of revenue | 41.0B | 16.8B | 14.0B | 14.8B |
Gross profit | 17.8B | 15.4B | 14.1B | 14.5B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 851M | 2.2B | 970M | 1.1B |
Non operating interest income | ||||
Income | 1M | 0 | 0 | 0 |
Expense | 135M | 33M | 34M | 34M |
Other income expense | — | — | — | — |
Pretax income | 1.6B | 2.4B | 1.1B | 1.2B |
Tax provision | 1.4B | 729M | 342M | 381M |
Net income | 258M | 1.7B | 800M | 815M |
Basic EPS | — | — | — | 22.4 |
Diluted EPS | — | — | — | 22.4 |
Basic average shares | — | — | — | 36.6M |
Diluted average shares | — | — | — | 36.6M |
EBITDA | 92M | 2.4B | 937M | 1.2B |
Net income from continuing op. | — | — | — | — |
Minority interests | 847M | -96M | -215M | 2M |
Preferred stock dividends | 0 | 0 | 0 | 0 |